2020-11-19 17:31

BioNTech and Pfizer will seek emergency US authorization for vaccine on Friday, CEO says i1Y世界播



BioNTech CEO predicts a return to normalcy in 2021 i1Y世界播


German company BioNTech and its partner, drug giant Pfizer, will ask the US on Friday to allow emergency use of their Covid-19 vaccine candidate, CEO Ugur Sahin told CNN during an exclusive interview on Wednesday. i1Y世界播


Sahin said the company will file paperwork for the emergency use of the vaccine with the US Food and Drug Administration (FDA). i1Y世界播


A final analysis of the Phase 3 trial of the vaccine shows it was 95% effective in preventing infections, even in older adults, and caused no serious safety concerns, Pfizer said Wednesday. i1Y世界播


The announcement of the BioNTech/Pfizer vaccine, followed this week by a similarly effective rival from the US company Moderna, raised spirits -- and stock markets -- across the world, as control of the virus finally appeared to be in sight. i1Y世界播

生物科技/辉瑞(BioNTech/Pfizer)疫苗的宣布,以及本周来自美国现代制药公司(Modern Na)的类似有效竞争对手的宣布,提振了世界各地的士气和股市,因为对病毒的控制似乎终于指日可待了。i1Y世界播

Sahin expects the vaccine's approval process to be completed and distribution to begin before the end of 2020. He said that if everything goes to plan, Covid-19 could be under control halfway through 2021. i1Y世界播


"Depending on how fast this [review] is really accomplished, we might get an authorization, or conditional approval already in 2020 which might help us start distribution of the first vaccine batches already in 2020," Sahin said, adding that he couldn't say exactly how long the review process would take. i1Y世界播



Pfizer's CEO sold $5.6 million in stock the day he announced promising vaccine news i1Y世界播


"When we submit packages we receive questions and of course addressing the questions takes time," he said. i1Y世界播


Sahin told CNN's Fred Pleitgen that BioNTech had already sent manufacturing data to the US regulator. i1Y世界播

沙欣告诉CNN的Fred Pleitgen,BioNTech已经向美国监管机构发送了制造业数据。i1Y世界播

"We met the requirements defined by the FDA and we of course communicated the manufacturing data," he said Wednesday. i1Y世界播


"Our goal is to supply several hundred million of doses in the first four to five months of 2021 and this is will already have an impact in the control of Covid-19," he said. i1Y世界播


"I am confident that if everything goes well, and we have a very organized vaccine supply, that we could have a normal summer and winter 2021." i1Y世界播


The BioNTech CEO did stress the important role governments had to play in the next phase of the pandemic. i1Y世界播


"[The] goal must be, of all governments, to ensure that there is a high vaccination rate in the population before we go into autumn," he said. i1Y世界播


A scientific power couple i1Y世界播


Sahin and his wife Ozlem Tureci have dedicated their lives to the field of oncology and infectious diseases. The pair set up BioNTech in the central German city of Mainz in 2008. i1Y世界播

沙欣和他的妻子奥兹莱姆·图雷奇(Ozlem Tureci)毕生致力于肿瘤学和传染病领域。2008年,这两家公司在德国中部城市美因茨成立了BioNTech。i1Y世界播

Both scientists come from Turkish backgrounds. Sahin was born in Iskenderun, a city on Turkey's Mediterranean coast. i1Y世界播


He met Tureci, the daughter of a Turkish physician, when the pair were both embarking on their scientific careers. i1Y世界播


In May, the couple told CNN they felt compelled to "provide something for society," given the work they had done in their field over the last two decades. i1Y世界播


"It is not important from where you come. It's important what you do," Sahin said Wednesday when asked about his roots. He said he and Tureci were both "devoted to science" and shared the same vision. i1Y世界播


"We never focused on ourselves. We always focused on our vision," he said. i1Y世界播



EU agrees to buy 300 million doses of the Pfizer/BioNTech Covid-19 vaccine i1Y世界播


Sahin also praised the pair's team at BioNTech, noting that some of the students he mentored had gone on to become leading scientists at the company. i1Y世界播


He said the team's next duty was to enable supply of the vaccine. i1Y世界播


The BioNTech and Pfizer vaccine needs to be stored at about minus 75 degrees Celsius, which is about 50 degrees colder than any vaccine currently used in the US. i1Y世界播


Concerns have been raised about the vaccine's transportation and storage needs. Sahin said BioNTech is working on a formula for its vaccine that could allow it to be shipped at room temperature. i1Y世界播


"Since the development was so fast, we were not able to work out better, more stable conditions," he said. i1Y世界播


"We believe that in the second half of 2021 we will have come up with a formulation which is comparable to any other type of vaccine." i1Y世界播


© 2016 世界播 中国互联网举报中心 京ICP证140141号 鄂ICP备18018000号-1